Startup profile · funding coverage
Aiforia startup funding profile
European institutional financing for ai-assisted pathology and cancer detection.
Stage
public
Status
public
Coverage
full
Overview
Aiforia is associated with European institutional financing for AI-assisted pathology and cancer detection. On 2026-08-09, it announced €20M in EIB financing. Undisclosed valuation, revenue and financing terms are not inferred.
Why Aiforia is interesting
August 2026: €20M in EIB financing, with the financing type preserved rather than flattened into a generic VC total.
Key facts
- EIB financing: €20M (August 2026)
- Financing classification: EIB financing
- Undisclosed terms remain undisclosed
Fundraising history
EIB financing
2026-08 €20MRelated funding articles
Venture Capital Tracker pieces that cover Aiforia's financing or category context.
FAQs about Aiforia
Practical answers founders, operators, and investors typically search for.
European institutional financing for ai-assisted pathology and cancer detection.
€20M in EIB financing, announced in August 2026.
Last updated: 2026-08-18